Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Nephrology 3, 16–17 (1 January 2007) | doi:10.1038/ncpneph0361
Is it premature to use calcineurin-inhibitor-free immunosuppression in pediatric renal transplantation?
Abstract
Harmon W et al. (2006) Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol 17: 1735–1745 Synopsis Background Calcineurin-inhibitor nephrotoxicity is believed to contribute to the progression of chronic allograft nephropathy.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
